Boston Scientific Corporation
corporate_fare Company Profile
Boston Scientific Corporation (NYSE:BSX) is a publicly traded company in the Life Sciences sector. Wiseek monitors BSX SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Boston Scientific to Cut Jobs in $800M Restructuring, Eyes $500M Annual Savings
- Boston Scientific Targets $500M in Annual Savings with $700M–$800M Restructuring
- Watchman Heart Device Usage Slowdown Sends Boston Scientific Shares Down 12%
- Boston Scientific's SEISMIQ Catheter Trial Exceeds Goals, Meets Safety & Effectiveness Endpoints
- Boston Scientific Initiates $2 Billion Accelerated Share Repurchase Program
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for BSX, detected from its recent SEC filings · based on capital-structure filings through 2026-04-01.
Definitive Merger Terms Filed · Merger Consideration Details
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Recent Capital Actions
-
2026-02-27 Proposed Mixed Merger +43.85M sh
-
2026-02-26 Executed Long-term debt ↓ −$3.27B (net of 7 line items)
-
2026-02-26 Executed Total debt ↓ −$3.27B (net of 7 line items)